We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Body-fluid Balance and Drinking Habits in Patients With Retinal Vascular Occlusion

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2013 by Dr. med. Evelyn Voigt, Dresden University of Technology.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01939119
First Posted: September 11, 2013
Last Update Posted: September 11, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. med. Evelyn Voigt, Dresden University of Technology
  Purpose
The purpose of this study is to examine the body-fluid balance in patients with retinal vascular occlusion and the influence of drinking habits and hemodilution on the degree of body hydration.

Condition
Dehydration Retinal Vascular Occlusion

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Examination of the Body-fluid Balance in Patients With Retinal Vascular Occlusion Before and During Hemodilution and the Influence of Drinking Habits on the Degree of Body Hydration

Resource links provided by NLM:


Further study details as provided by Dr. med. Evelyn Voigt, Dresden University of Technology:

Primary Outcome Measures:
  • changes in body-fluid balance [ Time Frame: 1 week ]
    The influence of hemodilution on body-fluid balance in patients with retinal vascular occlusion is examined


Secondary Outcome Measures:
  • number of participants with dehydration [ Time Frame: 1 week ]
    All patients are asked to fill in a questionnaire concerning their drinking habits (thirst, fluid intake). Patients body-fluid balance during hemodilution is measured with bioimpedance spectroscopy (Body Composition Monitor, Fresenius)


Estimated Enrollment: 30
Study Start Date: January 2013
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
retinal vascular occlusion
Patients with retinal vascular occlusion undergo a hematocrit dependent 5 day hemodilution

Detailed Description:
Patients with retinal vascular occlusion who are hospitalized for hemodilution and cardiovascular risk assessment are asked to report their drinking habits. Hydration status before and during hemodilution is assessed with a body-fluid analyzing scale.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with retinal vascular occlusion
Criteria

Inclusion Criteria:

  • informed consent
  • age over 18 years

Exclusion Criteria:

  • age under 18 years
  • hypertensive urgency
  • myocardial infarction < 4 weeks ago, chest pain
  • heart rhythm disorders, high degree valvular defects
  • pacemaker, defibrillator
  • peripheral arterial occlusive disease
  • end stage renal disease
  • acute hepatitis, chronic inflammatory intestinal disease
  • pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01939119


Contacts
Contact: Evelyn Voigt, MD 00493514583381 evelyn.voigt@uniklinikum-dresden.de
Contact: Karin Pillunat, MD 00493514583274 karin.pillunat@uniklinikum-dresden.de

Locations
Germany
University Eye Clinic Recruiting
Dresden, Germany/ Saxony, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Investigators
Study Director: Lutz E Pillunat, MD University Eye Clinic Dresden
  More Information

Responsible Party: Dr. med. Evelyn Voigt, Dr. med., Dresden University of Technology
ClinicalTrials.gov Identifier: NCT01939119     History of Changes
Other Study ID Numbers: VascOcclusion/Drinking2013
First Submitted: September 3, 2013
First Posted: September 11, 2013
Last Update Posted: September 11, 2013
Last Verified: September 2013

Keywords provided by Dr. med. Evelyn Voigt, Dresden University of Technology:
retinal vascular occlusion
drinking habits
body hydration
body-fluid balance

Additional relevant MeSH terms:
Dehydration
Water-Electrolyte Imbalance
Metabolic Diseases
Pathologic Processes